# Equitable Holdings, Inc.: financial statements, quarterly

EQH · NYSE · CIK 1333986 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eqh.md) · [Financials](/companies/eqh/financials.md) · [Filings](/companies/eqh/filings.md) · [Insiders](/companies/eqh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eqh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,633](/filings/0001333986-25-000020.md) | [2,109 d](/filings/0001333986-26-000012.md) | [2,230](/filings/0001333986-25-000020.md) | [3,507](/filings/0001333986-25-000049.md) | [3,073](/filings/0001333986-25-000068.md) | [3,615 d](/filings/0001333986-26-000012.md) | [4,576](/filings/0001333986-26-000025.md) | [2,362](/filings/0001333986-26-000040.md) | [1,450](/filings/0001333986-25-000068.md) | [3,277 d](/filings/0001333986-26-000012.md) | [4,230](/filings/0001333986-26-000025.md) | [1,658](/filings/0001333986-26-000040.md) |
| Interest expense | $m | [55.0](/filings/0001333986-23-000036.md) | [57.0 d](/filings/0001333986-24-000009.md) | [57.0](/filings/0001333986-24-000019.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [336](/filings/0001333986-25-000020.md) | [(227) d](/filings/0001333986-26-000012.md) | [24.0](/filings/0001333986-25-000020.md) | [116](/filings/0001333986-25-000049.md) | [(39.0)](/filings/0001333986-25-000068.md) | [179 d](/filings/0001333986-26-000012.md) | [24.0](/filings/0001333986-26-000025.md) | [(80.0)](/filings/0001333986-26-000040.md) | [(133)](/filings/0001333986-25-000068.md) | [33.0 d](/filings/0001333986-26-000012.md) | [156](/filings/0001333986-26-000025.md) | [(140)](/filings/0001333986-26-000040.md) |
| Net income | $m | [1,048](/filings/0001333986-25-000020.md) | [(697) d](/filings/0001333986-26-000012.md) | [92.0](/filings/0001333986-25-000020.md) | [428](/filings/0001333986-25-000049.md) | [(132)](/filings/0001333986-25-000068.md) | [892 d](/filings/0001333986-26-000012.md) | [63.0](/filings/0001333986-26-000025.md) | [(349)](/filings/0001333986-26-000040.md) | [(1,309)](/filings/0001333986-25-000068.md) | [215 d](/filings/0001333986-26-000012.md) | [621](/filings/0001333986-26-000025.md) | [(453)](/filings/0001333986-26-000040.md) |
| Diluted EPS | $ per share | [2.97](/filings/0001333986-25-000020.md) | not reported | [0.23](/filings/0001333986-25-000020.md) | [1.23](/filings/0001333986-25-000049.md) | [(0.46)](/filings/0001333986-25-000068.md) | not reported | [0.16](/filings/0001333986-26-000025.md) | [(1.21)](/filings/0001333986-26-000040.md) | [(4.47)](/filings/0001333986-25-000068.md) | not reported | [2.14](/filings/0001333986-26-000025.md) | [(1.68)](/filings/0001333986-26-000040.md) |
| Basic EPS | $ per share | [2.98](/filings/0001333986-25-000020.md) | not reported | [0.24](/filings/0001333986-25-000020.md) | [1.24](/filings/0001333986-25-000049.md) | [(0.46)](/filings/0001333986-25-000068.md) | not reported | [0.16](/filings/0001333986-26-000025.md) | [(1.21)](/filings/0001333986-26-000040.md) | [(4.47)](/filings/0001333986-25-000068.md) | not reported | [2.16](/filings/0001333986-26-000025.md) | [(1.68)](/filings/0001333986-26-000040.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [6.1](/filings/0001333986-23-000036.md) | [8.2](/filings/0001333986-25-000011.md) | [10.4](/filings/0001333986-24-000019.md) | [9.7](/filings/0001333986-24-000026.md) | [9.6](/filings/0001333986-24-000033.md) | [7.0](/filings/0001333986-26-000012.md) | [8.2](/filings/0001333986-25-000020.md) | [15.0](/filings/0001333986-25-000049.md) | [13.6](/filings/0001333986-25-000068.md) | [12.5](/filings/0001333986-26-000040.md) | [9.9](/filings/0001333986-26-000025.md) | [17.2](/filings/0001333986-26-000040.md) |
| Total assets | $bn | [260](/filings/0001333986-23-000036.md) | [277](/filings/0001333986-26-000012.md) | [285](/filings/0001333986-25-000020.md) | [288](/filings/0001333986-25-000049.md) | [299](/filings/0001333986-25-000068.md) | [296](/filings/0001333986-26-000012.md) | [287](/filings/0001333986-25-000020.md) | [303](/filings/0001333986-25-000049.md) | [314](/filings/0001333986-25-000068.md) | [318](/filings/0001333986-26-000040.md) | [310](/filings/0001333986-26-000025.md) | [335](/filings/0001333986-26-000040.md) |
| Total liabilities | $bn | [256](/filings/0001333986-23-000036.md) | [272](/filings/0001333986-26-000012.md) | [281](/filings/0001333986-25-000020.md) | [283](/filings/0001333986-25-000049.md) | [293](/filings/0001333986-25-000068.md) | [292](/filings/0001333986-26-000012.md) | [283](/filings/0001333986-25-000020.md) | [300](/filings/0001333986-25-000049.md) | [312](/filings/0001333986-25-000068.md) | [316](/filings/0001333986-26-000040.md) | [308](/filings/0001333986-26-000025.md) | [333](/filings/0001333986-26-000040.md) |
| Long-term debt | $bn | [3.8](/filings/0001333986-23-000036.md) | [3.8](/filings/0001333986-25-000011.md) | [3.8](/filings/0001333986-24-000019.md) | [3.8](/filings/0001333986-24-000026.md) | [3.8](/filings/0001333986-24-000033.md) | [3.8](/filings/0001333986-26-000012.md) | [4.3](/filings/0001333986-25-000020.md) | [4.3](/filings/0001333986-25-000049.md) | [3.8](/filings/0001333986-25-000068.md) | [3.8](/filings/0001333986-26-000040.md) | [3.8](/filings/0001333986-26-000025.md) | [3.8](/filings/0001333986-26-000040.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001333986-23-000036.md) | [0.3](/filings/0001333986-25-000011.md) | [0.0](/filings/0001333986-24-000019.md) | [0.0](/filings/0001333986-24-000026.md) | [0.0](/filings/0001333986-24-000033.md) | [0.0](/filings/0001333986-26-000012.md) | [0.0](/filings/0001333986-25-000020.md) | [0.0](/filings/0001333986-25-000049.md) | [0.0](/filings/0001333986-25-000068.md) | [0.0](/filings/0001333986-26-000040.md) | [0.0](/filings/0001333986-26-000025.md) | [0.0](/filings/0001333986-26-000040.md) |
| Shareholders' equity | $bn | [1.6](/filings/0001333986-23-000036.md) | [2.6](/filings/0001333986-26-000012.md) | [2.0](/filings/0001333986-25-000020.md) | [1.6](/filings/0001333986-25-000049.md) | [3.2](/filings/0001333986-25-000068.md) | [1.6](/filings/0001333986-26-000012.md) | [2.4](/filings/0001333986-25-000020.md) | [1.1](/filings/0001333986-25-000049.md) | [0.1](/filings/0001333986-25-000068.md) | [(0.1)](/filings/0001333986-26-000040.md) | [0.3](/filings/0001333986-26-000025.md) | [(0.8)](/filings/0001333986-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [411 d](/filings/0001333986-25-000020.md) | [(393) d](/filings/0001333986-26-000012.md) | [31.0](/filings/0001333986-25-000020.md) | [892 d](/filings/0001333986-25-000049.md) | [683 d](/filings/0001333986-25-000068.md) | [400 d](/filings/0001333986-26-000012.md) | [158](/filings/0001333986-26-000025.md) | [341 d](/filings/0001333986-26-000040.md) | [369 d](/filings/0001333986-25-000068.md) | [(154) d](/filings/0001333986-26-000012.md) | [499](/filings/0001333986-26-000025.md) | [643 d](/filings/0001333986-26-000040.md) |
| Dividends paid | $m | [77.0 d](/filings/0001333986-24-000033.md) | [74.0 d](/filings/0001333986-26-000012.md) | [73.0](/filings/0001333986-25-000020.md) | [78.0 d](/filings/0001333986-25-000049.md) | [76.0 d](/filings/0001333986-25-000068.md) | [75.0 d](/filings/0001333986-26-000012.md) | [74.0](/filings/0001333986-26-000025.md) | [82.0 d](/filings/0001333986-26-000040.md) | [81.0 d](/filings/0001333986-25-000068.md) | [77.0 d](/filings/0001333986-26-000012.md) | [76.0](/filings/0001333986-26-000025.md) | [83.0 d](/filings/0001333986-26-000040.md) |
| Share repurchases | $m | [238 d](/filings/0001333986-24-000033.md) | [241 d](/filings/0001333986-26-000012.md) | [253](/filings/0001333986-25-000020.md) | [247 d](/filings/0001333986-25-000049.md) | [254 d](/filings/0001333986-25-000068.md) | [260 d](/filings/0001333986-26-000012.md) | [262](/filings/0001333986-26-000025.md) | [235 d](/filings/0001333986-26-000040.md) | [676 d](/filings/0001333986-25-000068.md) | [277 d](/filings/0001333986-26-000012.md) | [147](/filings/0001333986-26-000025.md) | [366 d](/filings/0001333986-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [377](/filings/0001333986-23-000036.md) | [364](/filings/0001333986-24-000019.md) | [356](/filings/0001333986-25-000020.md) | [348](/filings/0001333986-25-000020.md) | [333](/filings/0001333986-25-000020.md) | [327](/filings/0001333986-25-000049.md) | [318](/filings/0001333986-25-000068.md) | [312](/filings/0001333986-26-000025.md) | [303](/filings/0001333986-26-000040.md) | [296](/filings/0001333986-25-000068.md) | [284](/filings/0001333986-26-000025.md) | [278](/filings/0001333986-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 273,035,157 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001333986-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.